Company news

ProQR Therapeutics N.V. news in 2025

ProQR Therapeutics N.V.'s news releases, calls and decks from 2025, newest first.

View company

ProQR to Participate in 8th Annual Evercore Healthcare Conference

December 1, 2025

ProQR Announces Third Quarter 2025 Operating and Financial Results

November 6, 2025

ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025

October 19, 2025

ProQR to Participate in Upcoming Investor Conferences in October 2025

October 13, 2025

ProQR Announces Second Quarter 2025 Operating and Financial Results

August 7, 2025

ProQR Announces Upcoming Presentation at RNA Editing Summit

July 28, 2025

ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP

June 26, 2025

ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences

May 12, 2025

ProQR Announces First Quarter 2025 Operating and Financial Results

May 8, 2025

ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference

May 2, 2025

ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025

May 1, 2025

ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth

April 14, 2025

ProQR Announces Year End 2024 Operating and Financial Results

March 13, 2025

Decks in 2025